Article
The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous-cell carcinoma: a meta-analysis.
Cancer medicine - 1 Jan 2017
Zhao Ziran, Wang Pan, Gao Yibo, He Jie
Abstract excerpt
Esophageal squamous-cell carcinoma (ESCC) is one of the deadliest cancers where biomarkers are needed for assist guiding management. We performed a meta-analysis to clarify the prognostic value of p53 high expression and TP53 mutations, which remain controversial for decades in patients with ESCC. We searched PubMed, Ovid MEDLINE, Embase, and Current Contents Connect to identify studies published between January...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
